Key result
Higher waist-to-height ratio linked to ~21% greater CAD risk per 0.1-unit increase in T1D.
Its licence doesn't allow us to show a copy here.
Why the study?
Obesity, kidney disease, and CAD are interconnected, prompting investigation into the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes.
Is central obesity (waist-to-height ratio ≥0.5) associated with an increased risk of coronary artery disease in individuals with type 1 diabetes?
Cohort (n=4,349)
Is central obesity (waist-to-height ratio ≥0.5) associated with an increased risk of coronary artery disease in individuals with type 1 diabetes?
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“As long as they have accumulation of fat in the center of body and they can develop this low-grade inflammation that also goes to insulin-load sensitivity, people with T1DM can accumulate fat in the liver as do people with T2DM and the general population.”
Waist-to-height ratio is a significant predictor of coronary artery disease risk in patients with type 1 diabetes, particularly among those without albuminuria.
Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes was investigated. Data on 4,349 individuals without prior CAD from the Finnish Diabetic Nephropathy Study were analyzed. Central obesity was defined as waist-to-height ratio (WHtR) ≥0.5. Outcomes included acute myocardial infarction, coronary revascularizations, and CAD-related death. Associations were assessed with Cox regression adjusted for baseline covariates. Over a median 19-year follow-up, 664 CAD events (15.3%) occurred. The 10- and 20-year cumulative CAD incidences were 11.6% and 25.3%, respectively, in those with central obesity versus 4.4% and 9.9% without, respectively. In multivariable analysis, the hazard ratio for CAD per 0.1-unit WHtR increase was 1.21 (95% CI, 1.06–1.38); P = 0.006) overall and 1.26 (95% CI, 1.02–1.56; P = 0.03) among those without albuminuria. In conclusion, WHtR is associated with increased CAD risk in type 1 diabetes, particularly among those without albuminuria.
Parente et al. (2026) conducted a cohort in Type 1 diabetes (n=4,349). Central obesity (waist-to-height ratio ≥0.5) vs. Without central obesity was evaluated on Acute myocardial infarction, coronary revascularizations, and CAD-related death (HR 1.21, 95% CI 1.06-1.38, p=0.006). A 0.1-unit increase in waist-to-height ratio was associated with a higher risk of coronary artery disease in type 1 diabetes (HR 1.21; 95% CI 1.06-1.38; P=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: